These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 1608680
1. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections. Uhari M, Seppänen J, Heikkinen E. Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680 [Abstract] [Full Text] [Related]
3. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Solomkin JS, Dellinger EP, Christou NV, Busuttil RW. Ann Surg; 1990 Nov; 212(5):581-91. PubMed ID: 2241313 [Abstract] [Full Text] [Related]
4. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Fichtenbaum CJ, Smith MJ. Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451 [Abstract] [Full Text] [Related]
5. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D. Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457 [Abstract] [Full Text] [Related]
11. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group. Eklund AE, Nord CE. J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657 [Abstract] [Full Text] [Related]
12. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Brismar B, Malmborg AS, Tunevall G, Wretlind B, Bergman L, Mentzing LO, Nyström PO, Kihlström E, Bäckstrand B, Skau T. Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347 [Abstract] [Full Text] [Related]
13. Use of imipenem-cilastatin in pediatrics. Overturf GD. Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788 [No Abstract] [Full Text] [Related]
17. Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States. Ahonkhai VI, Cyhan GM, Wilson SE, Brown KR. Pediatr Infect Dis J; 1989 Nov; 8(11):740-4. PubMed ID: 2687787 [Abstract] [Full Text] [Related]
18. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS, Pressler T, Jensen T, Rosdahl VT, Bentzon MW, Høiby N, Koch C. J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273 [Abstract] [Full Text] [Related]
19. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany. Knothe H. Infection; 1991 Jan; 19(3):127-30. PubMed ID: 1889863 [Abstract] [Full Text] [Related]
20. Imipenem-cilastatin monotherapy in severe infections accompanying hematological malignancies. Urabe A, Takaku F, Mizoguchi H. Jpn J Med; 1991 Jan; 30(5):420-3. PubMed ID: 1803041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]